Skip to main content

Table 2 Clinical specimens and M. abscessus complex (MABSC) clinical isolates

From: Clinical characteristics and drug susceptibility profiles of Mycobacterium abscessus complex infection at a medical school in Thailand

Specimens

N (%) of isolates

Total (N = 143)

MAB (N = 72)

MBO (N = 7)

MMA (N = 64)

Extrapulmonary

    

     Blood

3 (2.1)

1 (1.4)

2 (28.6)

0

     Pus/Wound aspirate

14 (9.8)

0

1 (14.3)

13 (20.3)

     Tissue biopsy

25 (17.5)

13 (18.1)

3 (42.9)

9 (14.1)

                             Total

42 (29.4)

14 (19.4)

6 (85.7)

22 (34.4)

Pulmonary(a)

    

     BAL

23 (16.1)

9 (12.5)

0

14 (21.9)

     Endotracheal aspirate

5 (3.5)

2 (2.8)

0

3 (4.7)

     Sputum

73 (51.0)

47 (65.3)

1 (14.3)

25 (39.1)

                            Total

101 (70.6)

58 (80.6)

1 (14.3)

42 (65.6)

                  Grand total

143 (100.0)

72 (100.0)

7 (100.0)

64 (100.0)

  1. (a) Respiratory specimens of patients with noncystic fibrosis that met the microbiological criteria for the diagnosis of NTM-PD according to the ATS/ERS/ESCMID/IDSA guideline
  2. Abbreviations: N, number; MABSC, M. abscessus complex; MAB, M. abscessus subsp. abscessus; MBO, M. abscessus subsp. bolletii; MMA, M. abscessus subsp. massiliense; BAL, Bronchoalveolar lavage
Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us